Pain Relief by Intra-Peritoneal Nebulization of Ropivacaine Under Remifentanil Anesthesia for Gynecological Laparoscopy — PSDR  

Gynecological Laparoscopy Clinical Trial

Official title: Phase 3 Prospective, Randomized, Controlled and Double-blinded Second Trial on Pain Relief by Continuous Intra-peritoneal Nebulization of Ropivacaine Under Remifentanil Anesthesia, During Gynecological Laparoscopic Surgery

Status Completed

Clinical Trial Summary

In our prospective, randomized, placebo controlled and double-blinded study we will study the efficacy of intraperitoneal ropivacaine nebulization on pain relief during gynecologic laparoscopic surgery. This is a second steady with protocol of general anesthesia used of Remifentanil.

Clinical Trial Description

Outcome Measures :

• VAS score

• Use of analgesics during operation and postoperative period ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Gynecological Laparoscopy

• NCT number: NCT00927979
• Study type: Interventional
• Source: Carmel Medical Center
• Status: Completed
• Phase: Phase 3
• Start date: June 2009
• Completion date: October 2010